171 related articles for article (PubMed ID: 1894189)
1. Hirudin in disseminated intravascular coagulation.
Nowak G; Markwardt F
Haemostasis; 1991; 21 Suppl 1():142-8. PubMed ID: 1894189
[TBL] [Abstract][Full Text] [Related]
2. Additive effect of the combined administration of low molecular weight heparin and recombinant hirudin on thrombus growth in a rabbit jugular vein thrombosis model.
Biemond BJ; Levi M; Nurmohamed MT; Büller HR; ten Cate JW
Thromb Haemost; 1994 Sep; 72(3):377-80. PubMed ID: 7855787
[TBL] [Abstract][Full Text] [Related]
3. Anticoagulant and antithrombotic actions of recombinant hirudin.
Kaiser B
Semin Thromb Hemost; 1991 Apr; 17(2):130-6. PubMed ID: 1837615
[No Abstract] [Full Text] [Related]
4. Dissolution of mural thrombus by specific thrombin inhibition with r-hirudin: comparison with heparin and aspirin.
Meyer BJ; Badimon JJ; Chesebro JH; Fallon JT; Fuster V; Badimon L
Circulation; 1998 Feb; 97(7):681-5. PubMed ID: 9495304
[TBL] [Abstract][Full Text] [Related]
5. Influence of hirudin on endotoxin-induced disseminated intravascular coagulation (DIC) in weaned pigs.
Nowak G; Markwardt F
Exp Pathol (Jena); 1980; 18(7-8):438-43. PubMed ID: 7439313
[TBL] [Abstract][Full Text] [Related]
6. Lepirudin blunts endotoxin-induced coagulation activation.
Pernerstorfer T; Hollenstein U; Hansen JB; Stohlawetz P; Eichler HG; Handler S; Speiser W; Jilma B
Blood; 2000 Mar; 95(5):1729-34. PubMed ID: 10688831
[TBL] [Abstract][Full Text] [Related]
7. Past, present and future of hirudin.
Markwardt F
Haemostasis; 1991; 21 Suppl 1():11-26. PubMed ID: 1894186
[TBL] [Abstract][Full Text] [Related]
8. Pharmacological effects of a novel recombinant hirudin, CX-397, in vivo and in vitro: comparison with recombinant hirudin variant-1, heparin, and argatroban.
Komatsu Y; Inoue Y; Goto Y; Fukazawa T; Hayashi H
Thromb Haemost; 1999 Feb; 81(2):250-5. PubMed ID: 10064001
[TBL] [Abstract][Full Text] [Related]
9. Endotoxin-induced disseminated intravascular coagulation in rabbits: effect of recombinant hirudin on hemostatic parameters, fibrin deposits, and mortality.
Hermida J; Montes R; Páramo JA; Rocha E
J Lab Clin Med; 1998 Jan; 131(1):77-83. PubMed ID: 9452130
[TBL] [Abstract][Full Text] [Related]
10. The effect of a long-acting recombinant hirudin (PEG-hirudin) on experimental disseminated intravascular coagulation (DIC) in rabbits.
Zawilska K; Zozulinska M; Turowiecka Z; Blahut M; Drobnik L; Vinazzer H
Thromb Res; 1993 Feb; 69(3):315-20. PubMed ID: 8475480
[TBL] [Abstract][Full Text] [Related]
11. Pharmacological survey of recombinant hirudin.
Markwardt F; Fink G; Kaiser B; Klöcking HP; Nowak G; Richter M; Stürzebecher J
Pharmazie; 1988 Mar; 43(3):202-7. PubMed ID: 3380865
[TBL] [Abstract][Full Text] [Related]
12. Effect of heparin, hirudin, and a synthetic thrombin inhibitor on antithrombin III in thrombin-induced disseminated intravascular coagulation in rats.
Hauptmann J; Brüggener E; Markwardt F
Haemostasis; 1987; 17(6):321-8. PubMed ID: 3428717
[TBL] [Abstract][Full Text] [Related]
13. Inhibition by recombinant hirudins of experimental venous thrombosis and disseminated intravascular coagulation induced by tissue factor in rats.
Freund M; Cazenave JP; Courtney M; Degryse E; Roitsch C; Bernat A; Delebassée D; Defreyn G; Maffrand JP
Thromb Haemost; 1990 Apr; 63(2):187-92. PubMed ID: 2363120
[TBL] [Abstract][Full Text] [Related]
14. Effect of recombinant hirudin, a specific inhibitor of thrombin, on endotoxin-induced intravascular coagulation and acute lung injury in pigs.
Hoffmann H; Siebeck M; Spannagl M; Weis M; Geiger R; Jochum M; Fritz H
Am Rev Respir Dis; 1990 Oct; 142(4):782-8. PubMed ID: 2221583
[TBL] [Abstract][Full Text] [Related]
15. Pharmacological studies on the antithrombotic action of hirudin in experimental animals.
Markwardt F; Hauptmann J; Nowak G; Klessen C; Walsmann P
Thromb Haemost; 1982 Jun; 47(3):226-9. PubMed ID: 7112494
[TBL] [Abstract][Full Text] [Related]
16. The effect of hirudin on endotoxin induced disseminated intravascular coagulation (DIC).
Ishikawa A; Hafter R; Seemüller U; Gokel JM; Graeff H
Thromb Res; 1980 Aug; 19(3):351-8. PubMed ID: 7434319
[No Abstract] [Full Text] [Related]
17. Comparison of enoxaparin, hirulog, and heparin as adjunctive antithrombotic therapy during thrombolysis with rtPA in the stenosed canine coronary artery.
Leadley RJ; Kasiewski CJ; Bostwick JS; Bentley R; McVey MJ; White FJ; Perrone MH; Dunwiddie CT
Thromb Haemost; 1997 Oct; 78(4):1278-85. PubMed ID: 9364998
[TBL] [Abstract][Full Text] [Related]
18. Effect of the administration of recombinant hirudin and/or tissue-plasminogen activator (t-PA) on endotoxin-induced disseminated intravascular coagulation model in rabbits.
Muñoz MC; Montes R; Hermida J; Orbe J; Páramo JA; Rocha E
Br J Haematol; 1999 Apr; 105(1):117-21. PubMed ID: 10233373
[TBL] [Abstract][Full Text] [Related]
19. Is thrombin a pharmacological target during reperfusion?
White HD
Blood Coagul Fibrinolysis; 1999 Feb; 10 Suppl 1():S55-7. PubMed ID: 10070820
[No Abstract] [Full Text] [Related]
20. An objective perspective on recombinant hirudin: a new anticoagulant and antithrombotic agent.
Fareed J; Walenga JM; Iyer L; Hoppensteadt D; Pifarre R
Blood Coagul Fibrinolysis; 1991 Feb; 2(1):135-47. PubMed ID: 1772981
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
